Literature DB >> 32147384

Future of evidence ecosystem series: 3. From an evidence synthesis ecosystem to an evidence ecosystem.

Philippe Ravaud1, Perrine Créquit2, Hywel C Williams3, Joerg Meerpohl4, Jonathan C Craig5, Isabelle Boutron6.   

Abstract

The "one-off" approach of systematic reviews is no longer sustainable; we need to move toward producing "living" evidence syntheses (i.e., comprehensive, based on rigorous methods, and up-to-date). This implies rethinking the evidence synthesis ecosystem, its infrastructure, and management. The three distinct production systems-primary research, evidence synthesis, and guideline development-should work together to allow for continuous refreshing of synthesized evidence and guidelines. A new evidence ecosystem, not just focusing on synthesis, should allow for bridging the gaps between evidence synthesis communities, primary researchers, guideline developers, health technology assessment agencies, and health policy authorities. This network of evidence synthesis stakeholders should select relevant clinical questions considered a priority topic. For each question, a multidisciplinary community including researchers, health professionals, guideline developers, policymakers, patients, and methodologists needs to be established and commit to performing the initial evidence synthesis and keeping it up-to-date. Encouraging communities to work together continuously with bidirectional interactions requires greater incentives, rewards, and the involvement of health care policy authorities to optimize resources. A better evidence ecosystem with collaborations and interactions between each partner of the network of evidence synthesis stakeholders should permit living evidence syntheses to justify their status in evidence-informed decision-making.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Evidence ecosystem; Evidence synthesis ecosystem; Living evidence; Living evidence synthesis; Living guidelines; Living meta-analysis; Living monitoring of quality; Living systematic review; Primary research; Systematic review

Mesh:

Year:  2020        PMID: 32147384     DOI: 10.1016/j.jclinepi.2020.01.027

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  6 in total

1.  Establishing a Regulatory Science System for Supervising the Application of Artificial Intelligence for Traditional Chinese Medicine: A Methodological Framework.

Authors:  Ying He; Qian Wen; Ying Wang; Juan Li; Ning Li; Rongjiang Jin; Nian Li; Yonggang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-02       Impact factor: 2.650

2.  Day-to-day discovery of preprint-publication links.

Authors:  Guillaume Cabanac; Theodora Oikonomidi; Isabelle Boutron
Journal:  Scientometrics       Date:  2021-04-18       Impact factor: 3.238

3.  Reading, Conducting, and Developing Systematic Review and Individual Patient Data Meta-Analyses in Psychiatry for Treatment Issues.

Authors:  Nadia Younes; Laurie-Anne Claude; Xavier Paoletti
Journal:  Front Psychiatry       Date:  2021-07-29       Impact factor: 4.157

4.  A Protocol of a Guideline to Establish the Evidence Ecosystem of Acupuncture.

Authors:  Qin Wang; Nian Li; Juan Li; Ying He; Yuxi Li; Dongling Zhong; Xiaobo Liu; Jin Fan; Rongjiang Jin; Deying Kang; Yonggang Zhang
Journal:  Front Med (Lausanne)       Date:  2022-02-15

5.  The COVID-NMA Project: Building an Evidence Ecosystem for the COVID-19 Pandemic.

Authors:  Isabelle Boutron; Anna Chaimani; Joerg J Meerpohl; Asbjørn Hróbjartsson; Declan Devane; Gabriel Rada; David Tovey; Giacomo Grasselli; Philippe Ravaud
Journal:  Ann Intern Med       Date:  2020-09-15       Impact factor: 25.391

6.  Using a Learning Health System to Improve Physical Therapy Care for Patients With Intermittent Claudication: Lessons Learned From the ClaudicatioNet Quality System.

Authors:  Anneroos Sinnige; Steffie Spruijt; Mickey Saes; Philip J Van der Wees; Thomas J Hoogeboom; Joep A W Teijink
Journal:  Phys Ther       Date:  2022-01-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.